Critical care

Pulmonary Fibrosis Foundation Announces PFF Summit 2023

Retrieved on: 
onsdag, september 27, 2023
CME, CE, Maintenance, Critical care, Federal, Drug development, Wake Forest School of Medicine, Education, Friends, Cystic Fibrosis Foundation, Convention, COVID-19, ILD, Research, COVID, CMO, Critical Role, Certification, Pulmonary fibrosis, Clinical trial, Boehringer Ingelheim, Hospice, Pharmacist, Patient, Division, Physician, Nursing, Nursing care plan, PFF, MOC, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Safety, PF, Lake, Conference, Food, Caregiver, Medical device, Nightclub, Medicine

CHICAGO, Sept. 27, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) will present its biennial PFF Summit 2023 from Nov. 9-11 in Orlando, Fla. The three-day international conference, focused on pulmonary fibrosis (PF) and interstitial lung disease (ILD) research and education, will be held at the JW Marriott Orlando Grande Lakes. The PFF Summit welcomes patients, caregivers, healthcare providers and researchers to discuss the latest information on treatment options and how to live well with PF and ILD.

Key Points: 
  • CHICAGO, Sept. 27, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) will present its biennial PFF Summit 2023 from Nov. 9-11 in Orlando, Fla.
  • "We are eager to connect patients with one another and with physicians and researchers at the PFF Summit 2023," said Dr. Franck Rahaghi, President, CEO and CMO of the PFF.
  • The PFF Summit 2023 features sessions tailored to each group's experience with PF.
  • The PFF Summit 2023 is made possible by the generous support of Boehringer Ingelheim, the Hales Family Foundation, and other individual and corporate donors.

Inteleos Unveils Two New Point-of-Care Ultrasound Certifications

Retrieved on: 
tisdag, september 26, 2023
IVC, European Information Technologies Certification Academy, Critical care, Arm, Education, DVT, Venae cavae, Inferior vena cava, Lung, Certification, POCUS, PCA, AAA, Health, Abdominal trauma, Abdominal aortic aneurysm, Nursing

ROCKVILLE, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Inteleos, a non-profit global healthcare certification organization, through its Point-of-Care Ultrasound (POCUS) Certification Academy (PCA), today announced the launch of an Inferior Vena Cava (IVC) certification and a Critical Care Specialty certification.

Key Points: 
  • ROCKVILLE, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Inteleos, a non-profit global healthcare certification organization, through its Point-of-Care Ultrasound (POCUS) Certification Academy (PCA), today announced the launch of an Inferior Vena Cava (IVC) certification and a Critical Care Specialty certification.
  • The PCA provides certification and educational resources for clinicians and is dedicated to ensuring quality patient care globally by upholding ultrasound standards with independently validated certifications.
  • The IVC Clinical Certificate and the Critical Care Specialty Certification include case-based assessments that simulate real-life clinical encounters and peer evaluations that determine practical skills and the user’s ability to interpret and diagnose findings.
  • “POCUS is not just an imaging tool, it's a compassionate touchpoint in patient care and a revolution in healthcare.

The Inner Circle Acknowledges, Phillip A. Villanueva as a Top Pinnacle Healthcare Professional for his contributions to the field of Neurosurgery

Retrieved on: 
fredag, september 22, 2023
Milltown Institute of Theology and Philosophy, Bachelor of Science in Human Biology, Critical care, University, Education, St. Thomas University (Florida), Temple University Hospital, Temple University, St. Thomas University, Neuroscience, Multimedia, Mentorship, Neurology, Inner circle, Philosophy, Congress of Neurological Surgeons, Medical degree, American Association of Neurological Surgeons, Brain, Chemistry, General surgery, ABNS, Neuro, Computational Biology and Chemistry, Dentistry, Theology, MD, Neurosurgery, Biology, Medicine

MEADOWBROOK, Pa., Sept. 22, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Mr. Phillip A. Villanueva, MD, ABNS, is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Neurosurgery.

Key Points: 
  • MEADOWBROOK, Pa., Sept. 22, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Mr. Phillip A. Villanueva, MD, ABNS, is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Neurosurgery.
  • The doctor has also created a series of public service announcements to increase community awareness of brain trauma outside of his neurology practice.
  • Dr. Villanueva has been recognized for excellence in service many times in his career, including the Best Doctors in America Award in Neurological Surgery (2019-2020).
  • Dr. Villanueva would like to dedicate this honor to his mentors, Hubert Rosomoff, MD; Barth Green, MD; and Bradley Ruben, MD.

VUNO's First AI-based Prospective Study Results Published in Critical Care

Retrieved on: 
måndag, september 18, 2023
Blood pressure, Real, Dong-a University Hospital, Cardiac arrest, Cohort (statistics), Bed, Respiratory rate, National Early Music Association, MFDS, MEWS, Research, Multimedia, AUROC, RWD, Real World, Thermoregulation, Korean Ministry of Culture, Seoul National University Hospital, Vital signs, Patient, Patient safety, UIT, NEWS, Trial of the century, Heart rate, Medical device, Pharmaceutical industry, Nursing, Critical care, Food

VUNO announced that the multicenter clinical study paper, which confirms the clinical validity of VUNO Med®-DeepCARS™ through its initial prospective research, has been published in "Critical Care," a leading international journal in intensive care medicine.

Key Points: 
  • VUNO announced that the multicenter clinical study paper, which confirms the clinical validity of VUNO Med®-DeepCARS™ through its initial prospective research, has been published in "Critical Care," a leading international journal in intensive care medicine.
  • In the study published in Critical Care, the VUNO research team conducted a multicenter study using patient data from general wards at four tertiary medical institutions: Seoul National University Hospital, Bundang Seoul National University Hospital, Inha University Hospital, and Dong-A University Hospital, each with varying sizes, locations, and medical environments.
  • The study found that the predictive performance of VUNO Med®-DeepCARS™ had an AUROC score of 0.869, outperforming traditional methods (NEWS 0.767, MEWS 0.756).
  • In this study, VUNO Med®-DeepCARS™ displayed exceptional predictive abilities and adaptability in identifying high-risk patients, even in its first prospective research.

Mindray Introduces Groundbreaking 2-in-1 Handheld Ultrasound Device with Multi-device Connectivity

Retrieved on: 
torsdag, september 7, 2023
Critical care, Emergency medicine, FAST, Workflow, TCI, Wireless, Lung, IOS, POCUS, Abdomen, Atmosphere of Earth, AAA, Hospital, Health, Heart, Medical imaging, Trauma

MAHWAH, N.J., Sept. 7, 2023 /PRNewswire/ -- Mindray, a global leader and developer of healthcare solutions and technologies in ultrasound, patient monitoring, and anesthesia, announced the launch of its TE Air Wireless Handheld Ultrasound, a new imaging solution that improves ultrasound accessibility. This compact, wireless technology enables healthcare professionals to carry comprehensive scanning capabilities in their pockets, adapting to a wide array of clinical scenarios. The TE Air is the industry's first handheld ultrasound device that can connect to either a mobile device or the touch-based TE X Ultrasound System, expanding its utility and accessibility.

Key Points: 
  • Mindray charges ahead and disrupts the point of care market again with its first wireless handheld ultrasound imaging solution expanding utility and accessibility for point of care ultrasound users.
  • MAHWAH, N.J., Sept. 7, 2023 /PRNewswire/ -- Mindray, a global leader and developer of healthcare solutions and technologies in ultrasound, patient monitoring, and anesthesia, announced the launch of its TE Air Wireless Handheld Ultrasound , a new imaging solution that improves ultrasound accessibility.
  • The TE Air is the industry's first handheld ultrasound device that can connect to either a mobile device or the touch-based TE X Ultrasound System , expanding its utility and accessibility.
  • Mindray introduces the first handheld wireless ultrasound that can connect to a mobile device or ultrasound system.

Pulmonary Fibrosis Foundation Names Dr. Franck Rahaghi New President, CEO and Chief Medical Officer

Retrieved on: 
tisdag, september 5, 2023
San Francisco, Pulmonary fibrosis, Abstract, American College of Chest Physicians, Critical care, Cleveland Clinic, Health policy, University, Education, Internal medicine, Cystic Fibrosis Foundation, ILD, Alternative medicine degrees, Research, Weill Cornell Medical Center, American Thoracic Society, Biomedical engineering, Consultant, Clinical professor, Government, Pulmonology, San Diego, Pulmonary hypertension, MHS, Publication, Biomedicine, MD, Pulmonary Hypertension Association, Berkeley, University of Illinois Urbana-Champaign, FCCP, Rockcastle Regional Hospital and Respiratory Care Center, Nursing care plan, PFF, Health, CCN, Pharmaceutical industry, Nursing, Medicine

CHICAGO , Sept. 5, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced Franck Rahaghi, MD, MHS, FCCP, as its incoming President, Chief Executive Officer and Chief Medical Officer, effective September 15. Following an extensive search, Dr. Rahaghi was selected based on his long-time commitment to care, research, and education in interstitial lung disease (ILD) and pulmonary fibrosis (PF). He will serve in an expanded role as President, CEO and Chief Medical Officer for the PFF.

Key Points: 
  • CHICAGO , Sept. 5, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced Franck Rahaghi, MD, MHS, FCCP, as its incoming President, Chief Executive Officer and Chief Medical Officer, effective September 15.
  • He will serve in an expanded role as President, CEO and Chief Medical Officer for the PFF.
  • In 2003, he joined the medical center as Staff Attending in Pulmonary Critical Care and Director of the Pulmonary Hypertension Clinic.
  • Dr. Rahaghi succeeds Bill Schmidt, former President and CEO of the PFF, and Dr. Joseph Lasky, the Foundation's former Chief Medical Officer.

The Inner Circle Acknowledges, Ruth S. Spector as a Pinnacle Life Member for his contributions to the fields of Internal Medicine, Anesthesia, and Critical Care Medicine

Retrieved on: 
torsdag, augusti 31, 2023
St. Vincent's Hospital, Critical care, Society, Education, MICU, Society of Critical Care Medicine, Health care, Gift of Life Marrow Registry, Good Samaritan Hospital, Business, Saint Vincent, MBA, Wharton School of the University of Pennsylvania, Private practice, Multimedia, American Society of Anesthesiologists, Mount Sinai Beth Israel, American Thoracic Society, Inner circle, GREAT, Tribe, Federal Executive Boards, Medical director, Patient, Data General Business Basic, Internal medicine, Knowledge, Hospital, Adelphi University, Fellow, George Washington University, Critical Care Medicine (journal), Injury, Nursing, Anesthesia, MD

GREAT NECK, N.Y., Aug. 31, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Ruth S. Spector, MD, FCCM, MBA, is acknowledged as a Pinnacle Life Member for his contributions to the fields of Internal Medicine, Anesthesia, and Critical Care Medicine.

Key Points: 
  • GREAT NECK, N.Y., Aug. 31, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Ruth S. Spector, MD, FCCM, MBA, is acknowledged as a Pinnacle Life Member for his contributions to the fields of Internal Medicine, Anesthesia, and Critical Care Medicine.
  • Dr. Spector pursued higher education earning a Bachelor of Science degree in General Business at Wharton School of Business.
  • She then obtained a medical degree from George Washington University and completed an Internal Medicine residency at Beth Israel Medical Center in NYC.
  • Board-certified in Internal Medicine, Anesthesia and Critical Care Medicine, Dr. Spector has more than 35 years of experience in the field.

CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil

Retrieved on: 
torsdag, augusti 31, 2023
Blood pressure, Fresenius Medical Care, Critical care, Surgeon, Shock, ANVISA, Oxygen, Cardiac surgery, COVID-19, Cytokine adsorbing column, COVID, Inflammation, Septic shock, Marketing, Professional corporation, Sepsis, Patient, Cytosorbents Corporation, FMC, Nursing care plan, ICU, Brazilian Health Regulatory Agency, Death, Pharmaceutical industry, Hospital

PRINCETON, N.J., Aug. 31, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that CytoSorb® was granted an expanded medical device registration by the Brazilian Health Regulatory Agency (ANVISA) to treat shock.

Key Points: 
  • PRINCETON, N.J., Aug. 31, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that CytoSorb® was granted an expanded medical device registration by the Brazilian Health Regulatory Agency (ANVISA) to treat shock.
  • After receiving its first ANVISA registration in September 2020 to treat cytokine storm in cardiac surgery and critical illnesses such as COVID-19 in the midst of the COVID pandemic, CytoSorb has now received an expanded ANVISA registration to also include the treatment of shock – a common and frequently fatal complication of critical illness and cardiac surgery.
  • Mr. Alexandre Franco, Marketing Director of FMC Brazil, stated, “Fresenius Brazil is very proud of the registration approval of CytoSorb by ANVISA, which will help anchor our Critical Care portfolio.
  • We are pleased to commercialize CytoSorb in Brazil under this expanded registration through our partners FMC and Contatti Medical, both well-established and connected experts in their respective clinical fields.

Eagle Pharmaceuticals to Present BYFAVO® (remimazolam) for Injection Abstract at Prestigious Society for Neuroscience in Anesthesiology and Critical Care (SNACC) Conference

Retrieved on: 
onsdag, augusti 30, 2023
Midazolam, Critical care, Medical Affairs Bureau, Society, Remimazolam, Central nervous system, DSM-IV codes, MD, Patient, Nursing care plan, Health, Fentanyl, Anesthesiology

WOODCLIFF LAKE, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it has been selected to present a platform presentation at the Society for Neuroscience in Anesthesiology and Critical Care (“SNACC”) Annual Meeting being held September 8-10, 2023, in Alexandria, VA.

Key Points: 
  • WOODCLIFF LAKE, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it has been selected to present a platform presentation at the Society for Neuroscience in Anesthesiology and Critical Care (“SNACC”) Annual Meeting being held September 8-10, 2023, in Alexandria, VA.
  • The conference is designed to meet the educational needs of neurosurgical and critical care anesthesiologists and neuroscientists involved in the care of patients with neurological disorders.
  • “Byfavo is the first new sedative to come to market in over 20 years, and we are extremely grateful for the opportunity to present this analysis to our esteemed colleagues in the perioperative neuroscience community,” stated Mike Greenberg, MD, Vice President of Medical Affairs at Eagle Pharmaceuticals.
  • “Gaining a better understanding of the potential impact of sedation agents on the central nervous system – as they relate to both short- and long-term changes in cognitive function – should help provide more precise patient care.

Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency

Retrieved on: 
onsdag, augusti 30, 2023
Emergent BioSolutions, Critical care, Emergency, Nasal spray, Life, Education, EBS, Naloxone, Policy, School, International Overdose Awareness Day, Patient, Love, OTC, University of Pennsylvania Health System, Family, Fentanyl, NYSE, Pharmaceutical industry, Emergent

Over-the-counter (OTC) access to NARCAN® Nasal Spray offers more people the ability to respond in an opioid emergency, helping to save lives and keep loved ones and communities safe.

Key Points: 
  • Over-the-counter (OTC) access to NARCAN® Nasal Spray offers more people the ability to respond in an opioid emergency, helping to save lives and keep loved ones and communities safe.
  • “Picking up NARCAN® Nasal Spray at the store is not a sign that your family has “a problem,” in fact it shows you are prepared just in case.
  • The Manufacturer’s Suggested Retail Price of NARCAN® Nasal Spray is $44.99 per carton, which is equivalent to roughly $22.50 per dose.
  • While Emergent works with partners to help maintain access and affordability, the price of the product is set by individual retailers.